(1,10b-dihydro-2-(aminocarbonyl-pheny l)-5H-pyrazolo(1,5c)(1,3)benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors

Details for Australian Patent Application No. 2005238235 (hide)

Owner Tibotec Pharmaceuticals Ltd.

Inventors Michiels, Lieve Emma Jan; Tahri, Abdellah; Van Acker, Koenraad Lodewijk August; Surleraux, Dominique Louis Nestor Ghislain

Agent Shelston IP

Pub. Number AU-B-2005238235

PCT Pub. Number WO2005/105810

Priority 04101913.4 04.05.04 EP; 60/604,275 25.08.04 US

Filing date 4 May 2005

Wipo publication date 10 November 2005

Acceptance publication date 7 July 2011

International Classifications

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

19 October 2006 PCT application entered the National Phase

  PCT publication WO2005/105810 Priority application(s): WO2005/105810

7 July 2011 Application Accepted

  Published as AU-B-2005238235

3 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005238241-Method for recovering gold

2005238223-Diastereoselective synthesis process for the preparation of imidazole compounds